Target intelligence / Profile preview

BAH domain and coiled-coil containing protein 1 (BAHCC1)

Target
BAHCC1
Molecular classification
Chromatin-associated protein, Epigenetic reader (BAH domain-containing), Other
01

Overview

BAH domain and coiled-coil containing protein 1 (BAHCC1) is a chromatin-associated protein characterized by a conserved bromo-adjacent homology (BAH) domain that specifically recognizes trimethylated histone H3 lysine 27 (H3K27me3)[1][3]. Through interaction with H3K27me3, BAHCC1 acts as a transcriptional corepressor, enforcing gene silencing of Polycomb target genes. It recruits additional repressive cofactors and links H3K27me3 recognition with histone deacetylation through interaction with HDACs, modulating chromatin structure and gene expression. BAHCC1 is overexpressed in some cancers (notably acute leukemia), and its depletion can derepress tumor suppressor and differentiation genes, highlighting its role in oncogenesis. Animal studies show that functional disruption of BAHCC1 interferes with normal development, underlining its crucial role in cell fate determination and chromatin organization[1][3][5][6].

Other names
BAH and coiled-coil domain-containing protein 1BAHD2KIAA1447BAH domain-containing protein 2bromo adjacent homology domain-containing protein 2BAHCC1
02

Mechanism of action

Drugs or molecules would be expected to act as inhibitors or disruptors of BAHCC1's interaction with H3K27me3 or associated corepressor complexes (mechanism characterized structurally and biochemically, but no current approved drugs)[1].

03

Biological functions

Chromatin bindingGene silencingRegulation of transcriptionChromatin organization(Predicted) neuron differentiation
04

Disease associations

Cancer (notably acute leukemia)Developmental disorders (e.g., postnatal lethality in mouse models, associated with KBG syndrome)
05

Safety considerations

Disruption in BAHCC1-H3K27me3 binding causes derepression of silenced genes, with consequences in gene expression regulation and development (e.g., partial postnatal lethality in animal models)[1].Essential role in developmental transcription regulation suggests widespread side effects if nonspecifically targeted.

Beyond the preview

Go deeper on BAH domain and coiled-coil containing protein 1 (BAHCC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAH domain and coiled-coil containing protein 1 (BAHCC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call